• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 202

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2026 May 9:108777.
doi: 10.1016/j.ijid.2026.108777. Online ahead of print.
Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 2025-26

Ying Shen[SUP] 1 [/SUP], Chunna Ma[SUP] 2 [/SUP], Daitao Zhang[SUP] 1 [/SUP], Weixian Shi[SUP] 2 [/SUP], Wei Duan[SUP] 2 [/SUP], Jia Li[SUP] 2 [/SUP], Lu Zhang[SUP] 2 [/SUP], Dan Wu[SUP] 2 [/SUP], Jiaojiao Zhang[SUP] 2 [/SUP], Jiaxin Ma[SUP] 2 [/SUP], Yingying Wang[SUP] 2 [/SUP], Xiaodi Hu[SUP] 2 [/SUP], Shuning Yan[SUP] 2 [/SUP], Yuanzhi Di[SUP] 2 [/SUP], Jiachen Zhao[SUP] 2 [/SUP], Hui Xu[SUP] 2 [/SUP], Guilan Lu[SUP] 2 [/SUP], Yimeng Liu[SUP] 2 [/SUP], Quanyi Wang[SUP] 3 [/SUP], Peng Yang[SUP] 3 [/SUP], Zhaomin Feng[SUP] 4 [/SUP]


Affiliations
Abstract

Background: Schools are high-risk settings for influenza transmission. During the 2025-26 Northern Hemisphere season, influenza A(H3N2) subclade K (J.2.4.1) rapidly emerged and became predominant, but vaccine effectiveness (VE) in school-associated outbreaks remains unclear.
Methods: We conducted a field investigation of 93 school-associated febrile outbreaks in Beijing, China, from September to December 2025. Cases were febrile students with laboratory-confirmed influenza, and afebrile classmates served as controls. VE against laboratory-confirmed symptomatic infection was estimated using mixed-effects logistic regression, adjusting for age, sex, school type, and outbreak-level clustering.
Results: A total of 3,797 students were included, of whom 788 were laboratory-confirmed febrile cases and 3,009 were afebrile classmates. Primary schools accounted for 74.2% of outbreaks. Overall vaccination rate was 54.6%, with 50.6% among cases and 56.1% among controls. Unadjusted VE was 19.6% (95% CI: 5.9-31.3). After adjustment, VE against laboratory-confirmed influenza was 30.0% (95% CI: 17.3-40.7). Sensitivity analyses yielded consistent results.
Conclusions: Influenza vaccination provided modest protection against symptomatic A(H3N2) infection in school-aged children, even under conditions of high-intensity exposure and antigenic drift. These findings underscore the value of vaccination in outbreak-prone school settings and highlight the importance of ongoing vaccine strain optimization and outbreak-based VE surveillance.

Keywords: H3N2; influenza; school outbreaks; vaccine effectiveness.

 
Back
Top Bottom